Log in to save to my catalogue

Population‐based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with rel...

Population‐based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with rel...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6abaa7e8bea8476ab19122439fb83e1e

Population‐based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma

About this item

Full title

Population‐based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma

Publisher

United States: John Wiley & Sons, Inc

Journal title

Clinical and translational science, 2022-12, Vol.15 (12), p.3000-3011

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

The aims of this work were to develop a population pharmacokinetic (PK) model for chimeric antigen receptor (CAR) transgene after single intravenous infusion administration of ciltacabtagene autoleucel in adult patients with relapsed or refractory multiple myeloma. CAR transgene level in blood were measured by quantitative polymerase chain reaction...

Alternative Titles

Full title

Population‐based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6abaa7e8bea8476ab19122439fb83e1e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6abaa7e8bea8476ab19122439fb83e1e

Other Identifiers

ISSN

1752-8054

E-ISSN

1752-8062

DOI

10.1111/cts.13421

How to access this item